Vendor, Radnor, PA
Immedica Pharma US Inc.
UEI MS6UM2NBDW91, CAGE 4BX80
2 awards and $0 obligated between January 2, 2024 and June 11, 2026, 100% under full and open competition, against 500.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Department of Veterans Affairs | $0 |
| Office of Assistant Secretary for Preparedness and Response | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50120C00159Definitive Contract, January 2, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Development of Intravenous Drug GanaxoloneNAICS 325412, PSC 6505 | $0 |
| 36F79724D0030December 3, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Public Law 2025 UpdatesNAICS 325412, PSC 6505 | $0 |
- Places of performance
- Pennsylvania
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 8 across 2 awards